Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age40-80
SponsorChinese PLA General Hospital

About this trial

This study will evaluate the safety and effectiveness of different surgical treatments for men with small-volume benign prostatic hyperplasia (BPH). Men with small-volume BPH may still have bothersome lower urinary tract symptoms and bladder outlet obstruction, and the best surgical treatment for this group remains uncertain.

In this multicentre, randomized, single-blind, four-arm controlled trial, 932 eligible men aged 40 to 80 years will be assigned in a 1:1:1:1 ratio to one of four groups: thulium laser enucleation of the prostate combined with bladder neck incision, thulium laser enucleation of the prostate alone, transurethral resection of the prostate (TURP), or transurethral incision of the prostate (TUIP).

The main goal of the study is to compare the incidence of bladder neck contracture at 6 months after surgery. Secondary outcomes include safety outcomes and changes in urinary symptoms, urinary flow rate, pain score, and symptom response at 3 and 6 months after surgery. Exploratory outcomes include changes in post-void residual urine volume and sexual function scores. Additional exploratory long-term outcomes will also be assessed at 12 months after surgery.

Eligibility criteria

Qualifiers

Male patients aged 40-80 years.

Diagnosis of benign prostatic hyperplasia (BPH) and scheduled to undergo surgical treatment.

International Prostate Symptom Score (IPSS) of at least 12, maximum urinary flow rate of no more than 15 mL/s, with a voided volume greater than 150 mL.

Prostate volume of less than 30 mL measured by transrectal ultrasound (TRUS), calculated as length × width × height × 0.52.

Disqualifiers

Inability or refusal to provide written informed consent, or inability to comply with the required follow-up schedule.

Prostate-specific antigen (PSA) level of 10 ng/mL or higher, unless prostate cancer has been excluded by biopsy.

Confirmed or suspected prostate or bladder malignancy.

Pre-existing bladder neck contracture or urethral stricture before surgery.

Trial design

Treatments tested in this trial

  • Thulium Laser Enucleation of the Prostate Combined With Bladder Neck Incision
  • Thulium Laser Enucleation of the Prostate
  • Transurethral Resection of the Prostate
  • Transurethral Incision of the Prostate

Treatment groups

932 Participants
are divided into 4 treatment groups

Sponsors and collaborators